Investigating the impact of Equol on brain health and Alzheimer's risk in women.
7T Vascular and Molecular Imaging of SVD: Sex, Equol, and Risk of Alzheimer’s Disease
This study is looking at how small blood vessel problems in the brain and Alzheimer's disease affect women, especially since they might be more at risk, and it will explore whether a natural compound called Equol can help protect brain health and lower the chances of dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11171420 on NIH RePORTER |
What this research studies
This research focuses on understanding how cerebral small vessel disease (SVD) and Alzheimer's disease (AD) interact, particularly in women who may be at higher risk due to sex-specific factors. The study will utilize advanced 7T vascular and molecular imaging techniques to assess changes in brain blood vessels and neurochemical markers associated with aging. By examining the effects of Equol, a compound with potential protective benefits for blood vessels, the research aims to identify ways to improve cerebrovascular health and reduce the risk of dementia. Patients may be involved in assessments that help clarify these relationships and the role of Equol in brain health.
Who could benefit from this research
Good fit: Ideal candidates for participation are older women, particularly those who have experienced menopause and may be at risk for Alzheimer's disease.
Not a fit: Patients who are not women or who are younger than the typical age of menopause may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease in women.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between cerebrovascular health and Alzheimer's disease, but this specific approach using 7T imaging and Equol is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Wu, Minjie — University of Pittsburgh at Pittsburgh
- Study coordinator: Wu, Minjie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.